Patient-Reported Outcomes Dashboard for Inflammatory Arthritis

MK
Overseen ByMAJA KUHARIC, Msc, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Northwestern University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether a new dashboard tool improves communication and decision-making between patients and doctors during rheumatology visits. The Patient-Reported Outcomes Dashboard With Goal Setting displays patient-reported symptoms and personal treatment goals for individuals with rheumatoid arthritis or psoriatic arthritis. Researchers aim to determine if the dashboard helps patients feel more involved in their care and achieve their health goals more effectively than with usual care. Participants should have rheumatoid or psoriatic arthritis, receive care at a Northwestern Medicine rheumatology clinic, and be able to complete online questionnaires. As an unphased trial, this study offers patients the opportunity to actively participate in research that could enhance their healthcare experience.

What prior data suggests that this dashboard is safe for use in rheumatology clinics?

Research has shown that a patient-reported outcomes (PRO) dashboard in rheumatology clinics is safe and easy for patients to use. In a study with over 6,000 patients, these dashboards, which display patient symptoms and treatment goals, were integrated without major issues. The dashboard enhances communication between patients and doctors, leading to better decision-making and health outcomes.

This technology does not require new medications or procedures. Instead, it uses existing health information to assist doctors. So far, no significant negative effects have been reported from using this type of dashboard, indicating its safety for patients.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it introduces a Patient-Reported Outcomes Dashboard with Goal Setting for individuals with inflammatory arthritis. Unlike standard care, which typically involves direct clinical assessments, this approach empowers patients to actively participate by setting personal treatment goals and providing detailed feedback on aspects like pain, fatigue, and sleep. This information is then shared with clinicians through a dashboard, potentially enhancing the personalization and effectiveness of treatment strategies. By aligning patient and clinician perspectives, this method could lead to more tailored and responsive care, ultimately improving patient satisfaction and outcomes.

What evidence suggests that this dashboard is effective for improving shared decision-making in inflammatory arthritis?

Research has shown that when patients use dashboards to share symptoms and goals with doctors, communication improves. In this trial, participants in the "PRO Dashboard With Goal Setting" arm will use such a dashboard to enhance communication with clinicians. Studies have found that this sharing leads to better teamwork in care. These tools help patients feel more involved in treatment decisions. As a result, patients often feel more in control of their symptoms and can achieve their personal health goals. These dashboards can also increase overall satisfaction with care by aligning treatment plans with patient preferences.

Are You a Good Fit for This Trial?

This trial is for adults diagnosed with rheumatoid arthritis or psoriatic arthritis who are receiving care at a rheumatology clinic. Participants should be able to complete questionnaires and attend two clinic visits about six months apart.

Inclusion Criteria

I am 18 years old or older.
I have been diagnosed with rheumatoid or psoriatic arthritis.
Receiving care at a Northwestern Medicine rheumatology clinic with an upcoming rheumatology visit
See 3 more

Exclusion Criteria

Unable to complete study questionnaires in English
I am not able to give informed consent for my treatment.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants complete routine symptom questionnaires and additional questionnaires in the patient portal before rheumatology visits, with results displayed on a dashboard for shared decision-making

6 months
2 visits (in-person) approximately 6 months apart

Follow-up

Participants are monitored for progress toward personal goals and shared decision-making effectiveness

6 months
Surveys completed before and after visits

What Are the Treatments Tested in This Trial?

Interventions

  • Patient-Reported Outcomes Dashboard With Goal Setting

Trial Overview

The study tests whether using a dashboard that shows patients' reported symptoms and personal goals to their doctor improves shared decision-making, goal progress, and confidence in managing symptoms compared to usual care.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: PRO Dashboard With Goal SettingExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwestern University

Lead Sponsor

Trials
1,674
Recruited
989,000+

Citations

Patient perceptions of an electronic-health-record-based ...

We developed an Electronic Heath Record-integrated, patient-facing side-car application to display RA outcomes (disease activity, functional ...

Incorporating PRO Data Into RA Clinical Encounters Using ...

The use of a dashboard visualizing patient-reported outcomes for rheumatoid arthritis improves shared decision making between patients and their providers and ...

“Am I OK?” using human centered design to empower ...

Use of patient reported outcomes (PROs) in the routine care of rheumatoid arthritis (RA) has been shown to improve health outcomes, However, integration of ...

Patient-Reported Outcomes in Inflammatory Arthritis

Results: A total of 6,308 patients with the specified conditions provided 277,574 PROs across four years from June 1, 2020, to May 31, 2024. Of those, 65.3% ...

A co-produced patient-reported outcomes-driven ...

A co-produced patient-reported outcomes-driven dashboard to support shared decision-making in rheumatologic diseases: a feasibility study ...